---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-031674"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2025-10-24T23:59:59+00:00"
generated_at: "2026-05-17T02:18:07.013923+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Federal court dismisses criminal indictment against Cassava's former collaborator Dr. Wang

## Summary
- U.S. District Court for Maryland granted unopposed motion to dismiss with prejudice all charges against Dr. Hoau-Yan Wang.
- Charges had accused Dr. Wang of causing false grant applications and fabricating research results including Western Blot images.
- Dismissal permanently terminates the case; no future charges can be refiled.
- Company reaffirms its simufilam program for TSC-related epilepsy based on research at multiple institutions.
- Cassava states support for integrity in scientific research and distances from the dismissed allegations.

## SEC filing metadata
- accession: 0001437749-25-031674
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2025-10-24T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774925031674/0001437749-25-031674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774925031674/sava20251024_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-031674
- JSON: https://secwatch.observer/filing/0001437749-25-031674.json
- Plain text: https://secwatch.observer/filing/0001437749-25-031674.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.